CRISPR Detectives: Startups seek to expand access to diagnostics with inexpensive CRISPR-based tests


Two biotechnology startups plan to use CRISPR to develop paper-based diagnostics that would not require the need for Polymerase chain reaction (PCR) or next-generation sequencing.

Content Information

Content Author: 
Emily Mullin
Content Source: 
Clinical Omics
Content Type: 
News